I'm LongbridgeAI, I can summarize articles.Moody’s (MCO) fell 4.16% this trading week to close at $493.55. The S&P 500 edged up 0.09%, leaving MCO roughly 4.25 percentage points behind the benchmark. The week started on a firm note: shares opened at $511.33 on Monday 31 Aug and hit an intraweek high of $511.94 before sliding lower through Tuesday and Wednesday. Wednesday’s low of $484.45 marked the trough, with a bounce to $504.30 on Thursday 3 Sep giving way to renewed softness on Friday; the stock closed at $493.55.
The Week
Moody’s (MCO) fell 4.16% this trading week to close at $493.55. The S&P 500 edged up 0.09%, leaving MCO roughly 4.25 percentage points behind the benchmark. The week started on a firm note: shares opened at $511.33 on Monday 31 Aug and hit an intraweek high of $511.94 before sliding lower through Tuesday and Wednesday. Wednesday’s low of $484.45 marked the trough, with a bounce to $504.30 on Thursday 3 Sep giving way to renewed softness on Friday; the stock closed at $493.55. Weekly amplitude was 5.38%. Average daily volume came to about 683k shares, roughly 17.5% below the recent median, pointing to a quieter tape.
Key Events
Company-specific news was light, with no earnings or major regulatory filings. Much of the weekly flow centred on the Moody Capital Solutions disruptive growth and life sciences conferences: a string of companies announced presentations, including 20Slash20, Vivos Therapeutics, Datavault AI, Cloudastructure, Pioneer Power Solutions, Cyabra Ltd and SafeSpace Global. On Wednesday 3 Sep, a filing disclosed that CEO Robert Fauber sold around $736,276 worth of common shares. On Friday 4 Sep, Maestria Partners LLC reported trimming its MCO stake. On the research side, Moody’s published a note saying policy reforms are reshaping financing and credit risks in China’s property ecosystem, the most substantive company output of the week.
Analyst Ratings
Coverage on MCO stands at 25 firms: 13 rate it buy, 5 overweight, 6 hold and 1 no opinion, with no underweight or sell ratings. The consensus recommendation is buy, and the consensus target is $561.90, about 13.85% above the current price. Targets range from $505.00 to $610.00, so views on upside are split; the low end sits near spot while the high end implies roughly 23.6% above the latest close. Moody’s ranks second among 26 peers in the financial exchanges and data industry.
The Week Ahead
The US macro calendar turns busier next week. Tuesday 8 Sep brings the NFIB small business optimism index, prior 99.8. Thursday 10 Sep is heavy: results from the 10-year Treasury auction, initial jobless claims, core and headline final demand PPI, existing home sales annualised, and wholesale sales. Several PPI prints are expected to accelerate from the prior reading, which could shape how markets price the inflation path. On the company side, follow-through from the conference presentations that dotted this week may continue to surface.
In Short
Moody’s spent the week under pressure while the broad market barely moved. The 4.16% drop came without a clear earnings or regulatory catalyst; the flow of news was mostly conference logistics, a modest CEO share sale, and one disclosed reduction by an institutional holder. The analyst picture remains supportive: the consensus is buy with a target that implies about 14% upside, though the wide $505-$610 target range shows real disagreement on how far that extends. Latest-session fund flow data shows some net selling, consistent with the week’s soft price and volume backdrop. The key watch next is whether upcoming PPI and claims data shift rate expectations, and whether conference-related disclosures or rating adjustments follow.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.